Health
FDA Approval Helps Immunocompromised Shingles Sufferers – Infection Control Today
Shingrix was originally approved by the FDA in 2017 for the prevention of shingles in adults 50 years and older. Now, it’s approved…
Adults aged 18 years and older with increased risk of immunodeficiency or immunosuppression have been given another means to fight the disease thanks to the approval by the US Food and Drug Administration (FDA) of the non-live, recombinant sub-unit adjuvanted…
Continue Reading
